Inflammatory Breast Cancer
📧 Sign up to get email alerts when something new happens for Inflammatory Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating neoadjuvant tipifarnib with docetaxel and capecitabine in adults with locally advanced or metastatic bre…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Phase II Neoadjuvant in Inflammatory Breast Cancer [Phase 2]
Phase II neoadjuvant trial in inflammatory breast cancer was terminated, with results posted on 2014-11-05.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer [Phase 2]
A Phase 2 trial evaluating the combination of trastuzumab, docetaxel, and carboplatin in women with stage II/III or inflammatory breast canc…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer [Phase 3]
Phase 3 trial assessing p53 biomarker analysis and sequence of combination chemotherapy followed by radiation therapy and surgery for women …
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer [Phase 1]
This Phase 1 trial assesses the efficacy and safety of bevacizumab given in the neoadjuvant setting for inflammatory breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating the three-drug combination of tipifarnib, doxorubicin, and cyclophosphamide in women with locally advanced breast c…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial comparing a standard doxorubicin/cyclophosphamide/paclitaxel regimen with or without filgrastim in women with inflammatory o…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer [Phase 3]
A Phase 3 trial evaluating combination chemotherapy with surgery and radiation, with or without Dexrazoxane and Trastuzumab, for stage III/I…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer [Phase 2]
A phase 2 clinical trial compared pazopanib plus lapatinib versus lapatinib alone in inflammatory breast cancer; results were posted in July…
-
CLINICAL_TRIALS research · 2012-07-16Clinical Trial Update: "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" [Phase 2]
Phase II clinical trial evaluating PET-guided neoadjuvant chemotherapy and Oncotype-guided hormonal therapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Dose-escalation Study of Oral CX-4945 [Phase 1]
Phase 1 dose-escalation study of CX-4945 in patients with various cancers is underway, including breast cancer, inflammatory breast cancer, …
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer [Phase 1]
Phase 1 trial evaluating SU5416 in combination with doxorubicin in stage IIIB or stage IV inflammatory breast cancer has completed.
-
CLINICAL_TRIALS research · 2010-04-23Clinical Trial Update: Establishing an Inflammatory Breast Cancer Registry
A completed clinical trial aimed at establishing an inflammatory breast cancer registry, sponsored by the National Cancer Institute, to coll…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating a multimodality treatment approach for inflammatory breast cancer and locally advanced or metastatic breas…
-
CLINICAL_TRIALS research · 2007-04-04Clinical Trial Update: Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [Phase 2]
A Phase 2 clinical trial evaluating a triple-drug regimen of docetaxel, carboplatin, and capecitabine before surgery for locally advanced or…